Literature DB >> 22503918

Preservation of small bowel with the selective use of heparin and second look laparotomy in acute mesenteric ischaemia: A case report.

Dina Fouad1, Shayanthan Nanthakumaran, Henry G Watson, Colin G Millar, Peter M King.   

Abstract

INTRODUCTION: Acute mesenteric ischaemia may occur due to mesenteric arterial embolus, thrombosis, non-occlusive mesenteric ischaemia or venous thrombosis resulting in ischaemia of the bowel wall. PRESENTATION OF CASE: A 41year old woman presented with worsening abdominal pain, decreased appetite, nausea and vomiting. Examination revealed right lower quadrant tenderness. Investigations revealed elevation of her inflammatory markers. At laparotomy two separate segments of ischaemic but potentially viable small bowel were identified secondary to mesenteric venous thrombosis. Bowel salvage was attempted with the use of intravenous unfractionated heparin and this was confirmed following a second look laparotomy. DISCUSSION: Despite a normal platelet count at presentation a diagnosis of JAK-2 positive essential thrombocythaemia was made thus explaining the acquired prothrombotic state underlying the venous thrombosis. The selective use of intravenous unfractionated heparin and second look laparotomy may provide a means for bowel preservation in these cases.
CONCLUSION: This case highlights the potential of bowel salvage can be achieved following an episode of acute mesenteric ischaemia with the use of intravenous unfractionated heparin and selective second look laparotomy and the importance of considering underlying myeloproliferative disease in such cases even in the absence of a thrombocytosis at presentation.
Copyright © 2012 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Year:  2012        PMID: 22503918      PMCID: PMC3356526          DOI: 10.1016/j.ijscr.2012.03.007

Source DB:  PubMed          Journal:  Int J Surg Case Rep        ISSN: 2210-2612


  18 in total

Review 1.  AGA technical review on intestinal ischemia. American Gastrointestinal Association.

Authors:  L J Brandt; S J Boley
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

2.  Mortality and morbidity of planned relaparotomy versus relaparotomy on demand for secondary peritonitis.

Authors:  B Lamme; M A Boermeester; E J T Belt; J W O van Till; D J Gouma; H Obertop
Journal:  Br J Surg       Date:  2004-08       Impact factor: 6.939

Review 3.  Intestinal ischemia: current treatment concepts.

Authors:  Philipp Renner; Klaus Kienle; Marc H Dahlke; Peter Heiss; Karin Pfister; Christian Stroszczynski; Pompiliu Piso; Hans J Schlitt
Journal:  Langenbecks Arch Surg       Date:  2010-11-12       Impact factor: 3.445

Review 4.  Epidemiology of mesenteric vascular disease: clinical implications.

Authors:  Stefan Acosta
Journal:  Semin Vasc Surg       Date:  2010-03       Impact factor: 1.000

5.  JAK2 V617F mutation, mesenteric vein thrombosis, and myeloproliferative disorders.

Authors:  Christopher D Owens
Journal:  J Vasc Surg       Date:  2010-07       Impact factor: 4.268

6.  JAK2 mutation status, hemostatic risk factors and thrombophilic factors in essential thrombocythemia (ET) patients.

Authors:  Bożena Sokołowska; Aleksandra Nowaczyńska; Ksenia Bykowska; Sylwia Chocholska; Katarzyna Wejksza; Adam Walter-Croneck; Tomasz Gromek; Anna M Kowalska; Martyna Kandefer-Szerszeń; Anna Dmoszyńska
Journal:  Folia Histochem Cytobiol       Date:  2011       Impact factor: 1.698

Review 7.  Contemporary management of acute mesenteric ischemia: Factors associated with survival.

Authors:  Woosup M Park; Peter Gloviczki; Kenneth J Cherry; John W Hallett; Thomas C Bower; Jean M Panneton; Cathy Schleck; Duane Ilstrup; William S Harmsen; Audra A Noel
Journal:  J Vasc Surg       Date:  2002-03       Impact factor: 4.268

8.  The role of intravenous fluorescein in the detection of colon ischemia during aortic reconstruction.

Authors:  R T Bergman; P Gloviczki; T J Welch; J M Naessens; T C Bower; J W Hallett; P C Pairolero; K J Cherry
Journal:  Ann Vasc Surg       Date:  1992-01       Impact factor: 1.466

9.  Platelet and coagulation activation markers in myeloproliferative diseases: relationships with JAK2 V6I7 F status, clonality, and antiphospholipid antibodies.

Authors:  B Robertson; C Urquhart; I Ford; J Townend; H G Watson; M A Vickers; M Greaves
Journal:  J Thromb Haemost       Date:  2007-05-21       Impact factor: 5.824

Review 10.  [Mesentric venous thrombosis. Risk factors, treatment and outcome. An analysis of 18 cases].

Authors:  C Lefrançois; A Derlon; A Le Querrec; A M Justum; P Gautier; J Maurel; Y Leroux; T Lochu; B Sillard; J P Deshayes
Journal:  Ann Fr Anesth Reanim       Date:  1994
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.